GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Research Alliance Corp II (NAS:RACB) » Definitions » Shares Outstanding (EOP)

Research Alliance II (Research Alliance II) Shares Outstanding (EOP) : 19.19 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Research Alliance II Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Research Alliance II's shares outstanding for the quarter that ended in Sep. 2022 was 19.19 Mil.

Research Alliance II's quarterly shares outstanding stayed the same from Jun. 2022 (19.19 Mil) to Sep. 2022 (19.19 Mil).

Research Alliance II's annual shares outstanding increased from Dec. 2020 (16.71 Mil) to Dec. 2021 (19.19 Mil). It means Research Alliance II issued new shares from Dec. 2020 to Dec. 2021 .


Research Alliance II Shares Outstanding (EOP) Historical Data

The historical data trend for Research Alliance II's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Research Alliance II Shares Outstanding (EOP) Chart

Research Alliance II Annual Data
Trend Dec20 Dec21
Shares Outstanding (EOP)
16.71 19.19

Research Alliance II Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shares Outstanding (EOP) Get a 7-Day Free Trial 19.19 19.19 19.19 19.19 19.19

Competitive Comparison of Research Alliance II's Shares Outstanding (EOP)

For the Shell Companies subindustry, Research Alliance II's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Research Alliance II's Shares Outstanding (EOP) Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Research Alliance II's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Research Alliance II's Shares Outstanding (EOP) falls into.



Research Alliance II Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Research Alliance II  (NAS:RACB) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Research Alliance II Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Research Alliance II's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Research Alliance II (Research Alliance II) Business Description

Traded in Other Exchanges
N/A
Address
3172 North Rainbow Boulevard, Suite 1278, Las Vegas, NV, USA, 89108
Research Alliance Corp II is a blank check company.
Executives
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Peter Kolchinsky director, officer: Chief Executive Officer 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Stephen J Hoffman director C/O SKYLINE VENTURES, 525 UNIVERSITY AVE., SUITE 1350, PALO ALTO CA 94301
Thomas Leggett director C/O AXCELLA HEALTH INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Matthew Hammond director, officer: Chief Investment Officer 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Research Alliance Holdings Ii Llc 10 percent owner 200 BERKELEY STREET 18TH FLOOR, BOSTON MA 02116
Theresa Cameron director, 10 percent owner, officer: Chief Financial Officer C/O THERAPEUTICS ACQUISITION CORP., 200 BERKELEY STREET. 18TH F L, BOSTON MA 02116
Clive Patience director C/O RESEARCH ALLIANCE CORP. II, 3172 NORTH RAINBOW BLVD. SUITE 1278, LAS VEGAS NV 89108

Research Alliance II (Research Alliance II) Headlines

From GuruFocus

Research Alliance Corp. II Will Redeem Public Shares

By Business Wire Business Wire 11-28-2022